Development and Validation of an HPLC Method for the Pharmacokinetic Study of Etodolac in Human |
Cho, Hea-Young
(Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital)
Kang, Hyun-Ah (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Moon, Jai-Dong (Medical School, Chonnam National University) Choi, Hoo-Kyun (College of Pharmacy, Chosun University) Lee, Yong-Bok (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) |
1 | J.P. Boni, J.M. Korth-Bradley, P. Martin, D.K. Simcoe, L.S. Richards, R. Rennebohm and P.D. Walson, Pharmacokinetics of etodolac in patients with stable juvenile rheumatoid arthritis, Clin. Ther., 21(10), 1715-1724 (1999) DOI ScienceOn |
2 | D.C. Braker and K.C. Lasseter, Profile of etodolac: phannacokinetic evaluation on special populations, Clin. Ther., 8(1), 25-35 (1989) |
3 | D.R. Brocks and F. Jamali, Etodolac clinical pharmacokinetics, Clin. Pharmacokinet., 26(4), 259-274 (1994) DOI ScienceOn |
4 | Martindale, The complete drug reference, 32 editions 1999, p. 32 (1999) |
5 | 식품의약품안전청 고시 제 2002-60호, 생물학적동등성시험기준 (2002. 11. 22) |
6 | U. Becker-Scharfenkamp and G. Blaschke, Evaluation of the stereoselective metabolism of the chiral analgesic drug etodolac by high-performance liquid chromatography, J. Chromatogr., 621(2), 199-207 (1993) DOI ScienceOn |
7 | Y.J. Lee, S.J. Chung and C.K. Shim, Bioavailability Analysis Program BA Calc. 2002 for Windows, Ver. 1.1.1, Seoul National University, Seoul, Korea (2002) |
8 | WinNonlinTM Users Guide Ver. 3.0, Pharsight Corp. Mountain View, CA, USA (1998-1999) |
9 | M.R. Koupai-Abyazani, B. Esaw and B. Laviolette, Etodolac in equine urine and detection, confirmation, and metabolite identification by atmospheric pressure ionization mass spectrometry, J. Toxicology, 23(3), 200-209 (1999) |
10 | R. Rothstein, Safety profiles of leading nonsteroidal anti-inflammatory drugs, Am. J. Med., 105(5A), 39-43S (1998) |
11 | L. Cosyns, M. Spain and M. Kraml, Sensitive high-performance liquid chromatographic method for the determination of etodolac in serum, J. Pharm. Sci., 72(3), 275-277 (1983) DOI |